Spots Global Cancer Trial Database for maintenance treatment
Every month we try and update this database with for maintenance treatment cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Olaparib in Patients With Recurrent Ovarian Cancer Wild Type for Germline and Somatic BRCA 1 and 2 Genes: The MITO 31 Translational Study | NCT04091204 | BRCA Wild Type ... | Olaparib tablet... | 18 Years - | National Cancer Institute, Naples | |
| Atezolizumab Plus Induction Chemotherapy Plus CT-radiotherapy. (APOLO) | NCT04776447 | Lung Diseases Carcinoma, Non-... Stage IIIA Non-... Stage IIIB Non-... Respiratory Tra... Carcinoma Bronc... Thoracic Neopla... | Carboplatin Placlitaxel Atezolizumab | 18 Years - 75 Years | Fundación GECP | |
| Clinical Study of Anlotinib in Maintenance Treatment of Advanced NSCLC | NCT03769805 | Nonsmall Cell L... | Anlotinib | 18 Years - 74 Years | The First Affiliated Hospital with Nanjing Medical University | |
| Rituximab Maintenance Treatment of Newly Diagnosed Follicular Lymphoma After BR or RCHOP or R2: a Multicenter Clinical Study | NCT04842318 | Follicular Lymp... | BR for 6 cycles... RCHOP for 6 cyc... R2 for 6 cycles... | 18 Years - | Ruijin Hospital | |
| Nivolumab and Ipilimumab Plus Chemotherapy for Patients With Stage IV Lung Cancer With Brain Metastases | NCT05012254 | Non Small Cell ... Brain Metastase... Lung Cancer | Ipilimumab Nivolumab Carboplatin Cisplatin Paclitaxel Pemetrexed | 18 Years - | Fundación GECP | |
| Maintenance Treatment With Capecitabine Metronomic Chemotherapy and Chinese Traditional Medicine in Metastatic Colorectal Cancer | NCT02575378 | Metastatic Colo... | Metronimic chem... Metronimic chem... | 18 Years - 75 Years | Ruijin Hospital | |
| Toripalimab as Maintenance Therapy in Patients With Driver-gene Negative Advanced NSCLC After First-line Chemotherapy | NCT04613804 | NSCLC Stage IV | Toripalimab Inj... | 18 Years - 75 Years | Fujian Cancer Hospital | |
| Phase II Study of Azacitidine and Sargramostim as Maintenance Treatment for Poor-Risk AML or MDS | NCT01700673 | Acute Myeloid L... Myelodysplastic... | Azacitidine Sargramostim | 6 Months - | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | |
| Icotinib as First-line and Maintenance Treatment in EGFR Mutated Patients With Lung Adenocarcinoma | NCT01665417 | EGFR Positive N... Adenocarcinoma | Experimental Chemotherapy Chemotherapy | 18 Years - 70 Years | Betta Pharmaceuticals Co., Ltd. | |
| Fruquintinib Plus FOLFIRI in RAS-mutated Metastatic Colorectal Cancer | NCT05842525 | Colorectal Canc... | intensive treat... Maintenance tre... | 18 Years - 75 Years | Hunan Cancer Hospital | |
| Consolidative Radiotherapy Plus Maintenance Chemotherapy for Metastatic Colorectal Cancer | NCT03142282 | Metastatic Colo... Radiotherapy | maintenance che... Consolidative R... | - | Wuhan Union Hospital, China | |
| Maintenance Metronomic Chemotherapy for Metastatic Colorectal Carcinoma | NCT01668680 | Colorectal Canc... | CAPECITABINE, C... | 18 Years - 80 Years | HaEmek Medical Center, Israel | |
| Alternating Treatment With Fruquintinib and Bevacizumab Plus Capecitabine as Maintenance Therapy After First-Line Treatment in Metastatic Colorectal Cancer | NCT05659290 | Metastatic Colo... | Fruquintinib al... Bevacizumab plu... | 18 Years - 75 Years | Nanfang Hospital, Southern Medical University | |
| VELCADE as Maintenance Treatment in Patients With Multiple Myeloma Following Autologous Peripheral Blood Stem Cell Transplantation (PBSCT) | NCT00311337 | Multiple Myelom... | bortezomib | 18 Years - | University of Wuerzburg | |
| Toripalimab as Maintenance Therapy in Patients With Driver-gene Negative Advanced NSCLC After First-line Chemotherapy | NCT04613804 | NSCLC Stage IV | Toripalimab Inj... | 18 Years - 75 Years | Fujian Cancer Hospital | |
| Nimotuzumab Plus S1 Versus Placebo Plus S1 as Maintenance Treatment in Patients With Unresectable Pancreatic Cancer | NCT02945267 | Unresectable Pa... | Nimotuzumab plu... Placebo plus S1 | 18 Years - 75 Years | Chinese PLA General Hospital | |
| Olaparib in Patients With Recurrent Ovarian Cancer Wild Type for Germline and Somatic BRCA 1 and 2 Genes: The MITO 31 Translational Study | NCT04091204 | BRCA Wild Type ... | Olaparib tablet... | 18 Years - | National Cancer Institute, Naples | |
| Maintenance Oral Vinorelbine or Observation After Vinorelbine-Docetaxel First Line Chemotherapy in Advanced Breast Ca | NCT02144194 | Breast Cancer | Vinorelbine-Doc... Vinorelbine | 18 Years - | Cancer Research Group - Collaborative Group, Beirut, Lebanon. | |
| Alternating Treatment With Fruquintinib and Bevacizumab Plus Capecitabine as Maintenance Therapy After First-Line Treatment in Metastatic Colorectal Cancer | NCT05659290 | Metastatic Colo... | Fruquintinib al... Bevacizumab plu... | 18 Years - 75 Years | Nanfang Hospital, Southern Medical University | |
| Elderly Patients With Acute Myeloid Leukemia (AML), Maintenance Phase After Complete Remission (CR) | NCT01301820 | Acute Myeloid L... | azacitidine Lenalidomide | 60 Years - 75 Years | French Innovative Leukemia Organisation | |
| Taxanes or Platinum in Combination With Capecitabine Followed by Capecitabine Alone as First Line Treatment for Patients With Advanced Adenocarcinoma of Stomach or Esophagogastric Junction | NCT01468389 | Gastric Cancer | Capecitabine capecitabine | 18 Years - 75 Years | The Affiliated Hospital of the Chinese Academy of Military Medical Sciences | |
| Haplo-SCT vs ASCT With or Without Decitabine in AML CR1 | NCT02059720 | Acute Myeloid L... | HSCT | 18 Years - | The First Affiliated Hospital of Soochow University | |
| Clinical Research of Pomalidomide Maintenance Therapy for Primary Multiple Myeloma | NCT05378971 | Multiple Myelom... | Pomalidomide | 18 Years - | LanZhou University | |
| Study of Thalidomide in Treatment of Advanced Nsclc (Dream-003) | NCT03062800 | Advanced Nsclc | Thalidomide pemetrexed cisplatin carboplatin | 18 Years - 70 Years | Qilu Hospital of Shandong University | |
| Avastin and Chemotherapy Followed by a KRAS Stratified Randomization to Maintenance Treatment for First Line Treatment of Metastatic Colorectal Cancer. | NCT01229813 | Colorectal Canc... | bevacizumab, er... bevacizumab bevacizumab low dose capeci... | 18 Years - | Lund University Hospital | |
| The Maintenance Treatment of Apatinib/Capecitabine Versus Observation in Advanced Gastric Cancer | NCT03889626 | Stomach Neoplas... Gastrointestina... Stomach Disease... Digestive Syste... Capecitabine Apatinib Neoplasms Molecular Mecha... | Apatinib Capecitabine | 18 Years - 90 Years | Fudan University | |
| Maintenance Treatment With Liposomal Doxorubicin (Caelyx) in Metastatic Breast Cancer Patients | NCT00128778 | Breast Neoplasm... | Pegylated lipos... | 18 Years - 90 Years | Spanish Breast Cancer Research Group | |
| A Single Arm, Open-label Clinical Trial to Evaluate the Efficacy and Safety of Maintenance Treatment With Capecitabine Plus Cetuximab in Metastatic Colorectal Cancer | NCT02717923 | Colorectal Neop... | maintenance tre... | - | Huazhong University of Science and Technology | |
| Phase II Study of Azacitidine and Sargramostim as Maintenance Treatment for Poor-Risk AML or MDS | NCT01700673 | Acute Myeloid L... Myelodysplastic... | Azacitidine Sargramostim | 6 Months - | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | |
| Avastin and Chemotherapy Followed by a KRAS Stratified Randomization to Maintenance Treatment for First Line Treatment of Metastatic Colorectal Cancer. | NCT01229813 | Colorectal Canc... | bevacizumab, er... bevacizumab bevacizumab low dose capeci... | 18 Years - | Lund University Hospital | |
| Olaparib in Patients With Recurrent Ovarian Cancer Wild Type for Germline and Somatic BRCA 1 and 2 Genes: The MITO 31 Translational Study | NCT04091204 | BRCA Wild Type ... | Olaparib tablet... | 18 Years - | National Cancer Institute, Naples | |
| Thalidomide Combined With Chemotherapy and Monotherapy for Maintenance Treatment for Her2-negative Advanced GC | NCT05198856 | Gastric Cancer ... | Thalidomide Com... | 18 Years - 75 Years | Qilu Hospital of Shandong University | |
| Study of Lenalidomide Maintenance Versus Placebo in Responding Elderly Patients With DLBCL and Treated With R-CHOP | NCT01122472 | Lymphoma Diffuse Large B... | Lenalidomide Placebo | 60 Years - 80 Years | The Lymphoma Academic Research Organisation | |
| Study of Lenalidomide Maintenance Versus Placebo in Responding Elderly Patients With DLBCL and Treated With R-CHOP | NCT01122472 | Lymphoma Diffuse Large B... | Lenalidomide Placebo | 60 Years - 80 Years | The Lymphoma Academic Research Organisation | |
| Linperlisib-based Treatment Regimen in Newly Diagnosed Nodal T-follicular Helper Cell Lymphoma (nTFHL) | NCT06347653 | Nodal T-follicu... | linperlisib com... | 18 Years - 65 Years | Peking University | |
| Clinical Study of Anlotinib in Maintenance Treatment of Advanced NSCLC | NCT03769805 | Nonsmall Cell L... | Anlotinib | 18 Years - 74 Years | The First Affiliated Hospital with Nanjing Medical University | |
| Evaluation of Afatinib in Maintenance Therapy in Squamous Cell Carcinoma of the Head and Neck | NCT01427478 | Head and Neck S... | AFATINIB Placebo of AFAT... | 18 Years - | Centre Leon Berard | |
| Nimotuzumab Plus S1 Versus Placebo Plus S1 as Maintenance Treatment in Patients With Unresectable Pancreatic Cancer | NCT02945267 | Unresectable Pa... | Nimotuzumab plu... Placebo plus S1 | 18 Years - 75 Years | Chinese PLA General Hospital | |
| Optimal Maintenance Therapy With Bevacizumab After Induction in Metastatic Colorectal Cancer (CRC) | NCT00973609 | Colorectal Neop... | 5-Fluorouracil,... 5-Fluorouracil,... 5-Fluorouracil,... | 18 Years - | AIO-Studien-gGmbH | |
| Taxanes or Platinum in Combination With Capecitabine Followed by Capecitabine Alone as First Line Treatment for Patients With Advanced Adenocarcinoma of Stomach or Esophagogastric Junction | NCT01468389 | Gastric Cancer | Capecitabine capecitabine | 18 Years - 75 Years | The Affiliated Hospital of the Chinese Academy of Military Medical Sciences | |
| Nimotuzumab Plus S1 Versus Placebo Plus S1 as Maintenance Treatment in Patients With Unresectable Pancreatic Cancer | NCT02945267 | Unresectable Pa... | Nimotuzumab plu... Placebo plus S1 | 18 Years - 75 Years | Chinese PLA General Hospital | |
| Phase II Study of NGR-hTNF Versus Placebo as Maintenance Treatment in Patients With Advanced MPM | NCT01358084 | Advanced Malign... | NGR-hTNF Placebo Best Supportive... | 18 Years - | AGC Biologics S.p.A. |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
